Motor carriers looking to blunt the impact of rising fuel costs may find relief in a familiar place — chassis pools. Consolidated Chassis Management (CCM) says its interoperable pooling model, ...
Yamaha Motor India has launched the 2026 Fascino 125 Fi Hybrid in India. As part of this update, the scooter now gets a refreshed design along with subtle updates. Prices for the model start at Rs ...
Yamaha Motor India has launched the updated 2026 Fascino 125 Fi Hybrid at prices starting from ₹76,500. The refresh brings a redesigned, more compact tail section with a distinctive V-shaped taillight ...
Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. After nearly half a century, Yamaha Motor Co. is moving its ...
Yamaha Motor Co., Ltd. has announced plans to relocate the headquarters of Yamaha Motor Corporation, U.S.A. from Cypress, California, to Kennesaw, Georgia. The transition is expected to take place in ...
Yamaha Motor Co., Ltd. has announced plans to relocate the headquarters of Yamaha Motor Corporation, U.S.A. from Cypress, California, to Kennesaw, Georgia. The transition is expected to take place in ...
This recall includes model year 2021-2025 Drive 2 Personal Transportation Vehicles (PTVs) Gas/Electric golf car vehicles. The recalled golf car vehicles were sold in a variety of colors. The following ...
MINNEAPOLIS, MN—A novel implantable device that provides both cardiac contractility modulation as well as defibrillation (CCM-D) successfully and safely delivers integrated therapy, while also ...
It's no secret that Yamaha's 125cc engine has a long, prestigious history. Rolled out shortly after the company's founding in February 1955, it powered Yamaha's first-ever motorcycle, the YA-1, to ...
I'm not entirely sure how you guys and gals feel about three-wheelers, but I personally find them to be the perfect vehicles for those who wish to travel through cities faster, but are not very ...
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3 rd-generation EGFR inhibitors and outperforms other investigational 4 th-generation inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results